Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	150.68	374.04	240.94	409.25	191.98	-
Short-Term Investments	220.96	79.94	130.94	-	-	-
Cash & Short-Term Investments	371.64	453.98	371.88	409.25	191.98	-
Cash Growth	14.63%	22.08%	-9.13%	113.18%	-	-
Other Receivables	1.63	0.94	0.92	0.2	0.15	-
Receivables	1.63	0.94	0.92	0.2	0.15	-
Prepaid Expenses	3.83	4.27	1.62	1.2	0.78	-
Restricted Cash	-	-	0.05	0.13	0.13	-
Other Current Assets	21.22	19.09	13.48	4.84	0.81	-
Total Current Assets	398.32	478.28	387.96	415.6	193.84	-
Property, Plant & Equipment	4.94	6.86	10.64	4.04	3.92	-
Long-Term Investments	-	9.85	23.51	-	-	-
Long-Term Deferred Charges	-	-	2.9	1.83	-	-
Other Long-Term Assets	1.21	1.21	1.23	7.82	0.18	-
Total Assets	404.47	496.2	426.23	429.3	197.95	-
Accounts Payable	1.08	0.34	7.15	1.64	2.4	-
Accrued Expenses	18.3	21.26	11.54	19.1	5.6	0.02
Current Portion of Leases	3.61	3.38	3.37	1.06	0.76	-
Other Current Liabilities	0.13	0.14	1.64	1.49	0.61	-
Total Current Liabilities	23.13	25.11	23.7	23.28	9.37	0.02
Long-Term Leases	-	1.85	5.07	1	1.28	-
Other Long-Term Liabilities	0.09	0.16	0.63	0.39	-	-
Total Liabilities	23.21	27.12	29.4	24.66	10.65	0.02
Common Stock	0.02	0.02	0	0.01	0.01	-
Additional Paid-In Capital	1,197	1,173	21.43	11.37	4.9	-
Retained Earnings	-815.86	-703.43	-467.51	-336.61	-99.29	-0.02
Comprehensive Income & Other	-0.19	-0.08	-0.77	-	-	-
Total Common Equity	381.26	469.08	-446.85	-325.22	-94.38	-0.02
Shareholders' Equity	381.26	469.08	396.84	404.64	187.3	-0.02
Total Liabilities & Equity	404.47	496.2	426.23	429.3	197.95	-
Total Debt	3.61	5.23	8.44	2.05	2.05	-
Net Cash (Debt)	368.03	458.6	386.95	407.2	189.93	-
Net Cash Growth	12.46%	18.51%	-4.97%	114.39%	-	-
Net Cash Per Share	2.84	7.05	14.22	18.60	14.61	-
Filing Date Shares Outstanding	160.03	158.89	32.61	31.98	30.61	-
Total Common Shares Outstanding	159.95	158.83	32.61	31.98	30.61	-
Working Capital	375.19	453.17	364.26	392.33	184.47	-0.02
Book Value Per Share	2.38	2.95	-13.70	-10.17	-3.08	-
Tangible Book Value	381.26	469.08	-446.85	-325.22	-94.38	-0.02
Tangible Book Value Per Share	2.38	2.95	-13.70	-10.17	-3.08	-
Machinery	-	3.18	2.94	2.3	1.83	-
Construction In Progress	-	0.04	0.51	0.22	-	-
Leasehold Improvements	-	-	0.02	0.26	0.21	-

Source: S&P Capital IQ. Standard template. Financial Sources.